Austen Neville, DPM
Podiatry · Houston, TXNPI 1811518624
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Treace Medical Concepts, Inc. accounts for 77.9% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $1,074, 2.8 times the $388 reported in 2023. Among podiatry clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $71.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Stryker$185
- Smith+Nephew$109
- KCI USA, Inc.$83
- Kowa Pharmaceuticals America, Inc.$34
What the payments were for
- Speaking & faculty fees$121%
- Travel & lodging$87947%
- Food & beverage$97052%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 20 | $1,450 |
| Stryker | 2 | $185 |
| Smith+Nephew | 2 | $109 |
| KCI USA, Inc. | 1 | $83 |
| Kowa Pharmaceuticals America, Inc. | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty$798
- Lapiplasty System$195
- HOFFMANN$162
How this compares
$1,861 in reported general payments places this provider in the 95th percentile of 51 podiatry providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nabumetone | 116 | $1,403 |
| Econazole Nitrate | 16 | $613 |
| Gabapentin | 85 | $523 |
| Methylprednisolone | 45 | $234 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $109 |
| Tramadol Hcl | 22 | $68 |
Paid to pharmacies, not to this prescriber.
Other podiatry in Houston
- Dana TateHouston$1K
- Michele TrbovichHouston$0
- Anetra MirandaHouston$0
- Qinyu LiHouston$0
- Donny LuongHouston$0
- William MitchellHouston$0
- Simon PanHouston$0
- Tiensi HoHouston$0
- Stuart PeissHouston$0
- Trang NguyenHouston$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.